Raaj Medisafe India Limited has reported a significant improvement in its financial performance for the quarter ended September 30, 2025. The company's board meeting, held on November 12, 2025, approved the unaudited financial results and several key business decisions.

Financial Highlights

The company's financial performance for Q2 FY2026 showed substantial growth compared to the same period last year:

For the half-year period ended September 30, 2025:

• Total revenue reached Rs 3,423.10 lakhs, up from Rs 2,343.00 lakhs in the previous year.
• Net profit increased to Rs 318.72 lakhs from Rs 162.58 lakhs, marking a 96% growth.

Key Business Decisions

The Board of Directors made several important decisions during the meeting:

1. Term Loan Approval: The company has approved availing a term loan of Rs 12.00 crores from Bank of Baroda, Indore.

2. Bank Account Shifting: Approval was given to shift the company's current and cash credit accounts from HDFC Bank, Teen Batti Branch Ujjain to HDFC Bank, Maksi Road, Ujjain.

3. Share Forfeiture: The Board approved the forfeiture of 63,300 equity shares due to non-payment of calls in arrears.

Other Notable Points

• The company's financial results were reviewed by the audit committee and approved by the Board of Directors.
• GDK & Associates, Chartered Accountants, conducted a review of the financial statements and found no material misstatements.
• The board meeting, which commenced at 3:00 PM, concluded at 5:00 PM.

Raaj Medisafe India Limited, with its registered office in Ujjain, Madhya Pradesh, continues to show strong growth in its operations. The significant increase in revenue and profitability indicates the company's focus on expansion and operational efficiency.

Investors and stakeholders may view these results positively, especially considering the substantial improvement in earnings per share. The approval of a new term loan suggests that the company may be preparing for future growth opportunities.

Raaj Medisafe India Limited has reported a robust financial performance for the quarter, marked by significant revenue growth and the successful launch of a new hygiene segment. The company's strategic diversification and strong execution have yielded impressive results across key financial metrics.

Financial Highlights

• Revenue Growth: The company's revenue soared by 45.10% to ₹158.27 crores, compared to ₹109.06 crores in the same quarter of the previous year.
• Net Profit: Net profit saw a substantial increase of 50.00%, reaching ₹14.61 crores, up from ₹9.74 crores in the corresponding quarter.
• EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) grew by 51.60% to ₹26.28 crores, with the EBITDA margin improving to 16.60% from 15.90% year-over-year.
• Earnings Per Share (EPS): EPS rose to ₹1.11 from ₹0.74 in the same quarter last year.

Segment Performance

The company's performance was bolstered by its two main segments:

Hygiene Segment

• Newly launched segment producing sanitary napkins and diapers
• Contributed ₹42.29 crores, accounting for 26.70% of total revenue
• Achieved an EBIT margin of 18.30%

Plastic Segment

• Grew by 6.60% to ₹116.26 crores
• EBIT margin improved significantly to 15.30% from 10.50% in the previous year

Balance Sheet Strength

• Total Assets: Grew by 18.10% to ₹817.71 crores
• Debt-to-Equity Ratio: Stood at 2.04

Management Commentary

Arpit Bangur, Chairman and Managing Director of Raaj Medisafe India Limited, stated, "Our strong performance this quarter reflects the success of our diversification strategy and operational excellence. The new hygiene segment has exceeded our expectations, contributing significantly to our overall growth. We remain committed to innovation and expanding our product portfolio to meet evolving consumer needs."

Corporate Updates

In addition to the financial results, the company announced several key corporate updates:

1. Appointment of CFO: Ms. Fatima Dadani, a Chartered Accountant with over 7 years of professional experience, has been appointed as the new Chief Financial Officer effective August 11, 2025.

2. Auditor Appointments:

   • M/s. M Maheshwari & Associates have been appointed as Secretarial Auditors for a five-year term (2025-26 to 2029-30).
   • M/s. GDK & Associates are proposed to be appointed as Statutory Auditors, subject to approval at the upcoming Annual General Meeting.

3. Annual General Meeting: The 40th Annual General Meeting is scheduled for September 25, 2025, to be held via video conferencing.

Raaj Medisafe India Limited's strong quarterly performance, coupled with strategic appointments and expansion into the hygiene segment, positions the company for continued growth. Investors and stakeholders will be keenly watching how the company leverages its new segment and maintains its growth trajectory in the competitive market landscape.